Vnitr Lek 2005, 51(4):385-387

Význam monitorování hladin α-fetoproteinu u chronických infekcí viry hepatitidy B a C - editorial

P. Husa
Klinika infekčních chorob Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta doc. MUDr. Petr Husa, CSc.

Received: June 22, 2004; Published: April 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P. Význam monitorování hladin α-fetoproteinu u chronických infekcí viry hepatitidy B a C - editorial. Vnitr Lek. 2005;51(4):385-387.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol 2003; 38 (Suppl 1): S104-S118. Go to original source... Go to PubMed...
    2. Galský J, Husa P, Kümpel P et al. Diagnostika a léčba chronické virové hepatitidy C (HCV). Doporučený postup České hepatologické společnosti a Společnosti infekčního lékařství z roku 2002. Klin Mikrobiol Inf Lék 2003; 9: 54-56.
    3. Graig JR. Tumors of the liver. In: Zakim D, Boyer TD (eds). Hepatology. A Textbook of Liver Disease. 4th ed. Philadelphia: WB Saunders 2003: 1017-1062.
    4. Husa P, Šperl J, Galský J et al. Diagnostika a léčba chronické virové hepatitidy B. Doporučený postup České hepatologické společnosti a Společnosti infekčního lékařství - aktualizace březen 2003. Klin Mikrobiol Inf Lék 2003; 9: 51-54.
    5. Johnson PJ. Malignant tumors of the liver. In: O'Grady JG, Lake JR, Howdle PD (eds). Comprehensive Clinical Hepatology. London: Mosby 2000: 3.25.1-3.25.18.
    6. Lok ASF, McMahon BJ. Chronic hepatitis B. AASLD Practice Guideline. Hepatology 2001; 34: 1225-1241. Go to original source... Go to PubMed...
    7. Manns MP. Hepatitis C: a heterogeneous disease amongst heterogeneous patients. The hepatitis C Forum, Rhodos, 19. - 22. 9. 2002. Abstract book, 9-11.
    8. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002. Final Statement August 26, 2002. http://consensus.nih.gov/cons/116/091202116cdc_statement.htm
    9. Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 11th ed. Oxford: Blackwell Science 2002. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.